-
2
-
-
83155161046
-
Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy
-
Rosenberg VA, Buhimschi IA, Lockwood CJ, Paidas MJ, Dulay AT, Ramma W, Abdel-Razeq SS, Zhao G, Ahmad S, Ahmed A, Buhimschi CS: Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy. Circulation 2011; 124:2543-2553.
-
(2011)
Circulation
, vol.124
, pp. 2543-2553
-
-
Rosenberg, V.A.1
Buhimschi, I.A.2
Lockwood, C.J.3
Paidas, M.J.4
Dulay, A.T.5
Ramma, W.6
Abdel-Razeq, S.S.7
Zhao, G.8
Ahmad, S.9
Ahmed, A.10
Buhimschi, C.S.11
-
3
-
-
80054933594
-
Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium
-
Dogan OT, Polat ZA, Karahan O, Epozturk K, Altun A, Akkurt I, Cetin A: Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium. Thromb Res 2011; 128:29-32.
-
(2011)
Thromb Res
, vol.128
, pp. 29-32
-
-
Dogan, O.T.1
Polat, Z.A.2
Karahan, O.3
Epozturk, K.4
Altun, A.5
Akkurt, I.6
Cetin, A.7
-
4
-
-
84855297285
-
Effect of Low Molecular Weight Heparins (LMWHs) on Antiphospholipid Antibodies (aPL) - Mediated Inhibition of Endometrial Angiogenesis
-
D'Ippolito S, Marana R, Di Nicuolo F, Castellani R, Veglia M, Stinson J, Scambia G, Di Simone N: Effect of Low Molecular Weight Heparins (LMWHs) on Antiphospholipid Antibodies (aPL) - Mediated Inhibition of Endometrial Angiogenesis. PLoS ONE 2012; 7:29660.
-
(2012)
PLoS ONE
, vol.7
, pp. 29660
-
-
D'Ippolito, S.1
Marana, R.2
Di Nicuolo, F.3
Castellani, R.4
Veglia, M.5
Stinson, J.6
Scambia, G.7
Di Simone, N.8
-
5
-
-
33644830185
-
Low-molecular-weight heparins and angiogenesis
-
114281
-
Norrby K: Low-molecular-weight heparins and angiogenesis. APMIS 2006; 114281:79-102.
-
(2006)
APMIS
, pp. 79-102
-
-
Norrby, K.1
-
6
-
-
14744305444
-
Anti-angiogenic mechanisms and efficacy of the low molecular 308 weight heparin, tinzaparin: anti-cancer efficacy
-
Mousa SA, Mohamed S: Anti-angiogenic mechanisms and efficacy of the low molecular 308 weight heparin, tinzaparin: anti-cancer efficacy. Oncol Rep 2004; 12:683-688.
-
(2004)
Oncol Rep
, vol.12
, pp. 683-688
-
-
Mousa, S.A.1
Mohamed, S.2
-
7
-
-
84859421483
-
Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay
-
Katrancioglu N, Karahan O, Kilic AT, Altun A, Katrancioglu O, Polat ZA: Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay. Blood Coagul Fibrinolysis 2012; 23:218-221.
-
(2012)
Blood Coagul Fibrinolysis
, vol.23
, pp. 218-221
-
-
Katrancioglu, N.1
Karahan, O.2
Kilic, A.T.3
Altun, A.4
Katrancioglu, O.5
Polat, Z.A.6
-
8
-
-
0035672780
-
Excretion of low molecular weight heparin in human milk
-
Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R: Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol 2001; 52:708.
-
(2001)
Br J Clin Pharmacol
, vol.52
, pp. 708
-
-
Richter, C.1
Sitzmann, J.2
Lang, P.3
Weitzel, H.4
Huch, A.5
Huch, R.6
|